KLAS product ratings are determined from detailed responses by healthcare providers as compiled over a 13-month period by KLAS Enterprises, LLC. Data contained in the 2005 publication show that QuadraMed client satisfaction continues to gain high marks.
"Our intent is to offer healthcare providers real value, and our ratings in this KLAS report indicate QuadraMed is meeting their expectations," said QuadraMed President and CEO Keith Hagen. "Gaining top overall scores for five of our offerings confirms the high level of client satisfaction we've set out to achieve.
"Based on the results our clients are reporting, hospitals planning to evaluate IT solutions would do well by looking at QuadraMed's products," added Mr. Hagen.
In the 2005 Best in KLAS award commentary, QuadraMed Affinity clients noted that the system is "very user friendly" with "good documentation", is designed "so we don't have to buy a lot of add-on systems to integrate", and the company is "responsive" to problems. In the "Community HIS" category, QuadraMed Affinity received the highest percentage of "would buy again" responses.
More detail on product achievements:
- QuadraMed MPI (Master Patient Index) took the top rating for EMPI in "Specialty Niche Category Leaders", where 89 percent of comments were positive.
- QuadraMed Affinity Clinicals are rated number one in the "Community Clinical & Ancillary Solutions" category for Acute Care CDR, Orders and Charting products, receiving the highest percentage of respondents rating the company as the best vendor.
- QuadraMed Pharmacy again was rated number one and increased its rating in the "Community Clinical and Ancillary Solutions" category for Pharmacy Current Products.
- QuadraMed WinPFS (Acuity, Productivity and Benchmarking System) in the "Specialty Niche" category for Other Specialty Products, took the top overall score, with 89 percent positive commentary.
- QuadraMed EDM (Electronic Document Management) moved into the regular ratings finishing in fourth place for "Document Management & Imaging" with 100 percent of respondents reporting they would buy the product again.
QuadraMed delivers industry-leading "care-based" revenue cycle management products. These solutions create long-term client partnerships and enable community hospitals and other healthcare organizations to achieve the highest value from their IT investments.
More about KLAS Enterprises is available at www.healthcomputing.com. Further information about QuadraMed, its products and related services is available by visiting www.quadramed.com, or by calling 800-393-0278.
About KLAS Enterprises
Founded in 1996, KLAS is the only research firm specializing in monitoring and reporting the performance of healthcare information technology (HIT) vendors and products. KLAS strives to improve HIT delivery by independently measuring vendor performance for the benefit of consultants, investors, vendors, and healthcare provider partners. KLAS, in concert with thousands of healthcare executives and professionals, has created a dynamic database of HIT evaluations and opinions of healthcare executives, managers, and clinicians from over 4,500 healthcare facilities and 2500 clinics on 500+ HIT products from 175+ vendors. The Top 20 Report reflects the summary of HIT product performance data collected over a 13-month period. For further information, contact KLAS Enterprises, LLC at 800-920-4109 or on the Web at www.healthcomputing.com.
About QuadraMed Corporation
QuadraMed is dedicated to improving healthcare delivery by providing innovative healthcare information technology and services. From clinical and patient access management to revenue cycle and health information management, QuadraMed delivers real-world solutions that help healthcare professionals deliver outstanding patient care with optimum efficiency. Behind our products and services is a staff of almost 700 professionals whose experience and dedication to service have earned QuadraMed the trust and loyalty of customers at approximately 2,000 healthcare provider facilities. To find out more about QuadraMed, visit www.quadramed.com.
Cautionary Statement on Risks Associated with QuadraMed's Forward-Looking Statements
This press release contains forward-looking statements by QuadraMed within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. The words "believe," "expect," "anticipate," "intend," "plan," "estimate," "may," "should," "could," and similar expressions are intended to identify such statements. Forward-looking statements are not guarantees of future performance and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement except as required by law. QuadraMed advises investors that it discusses risk factors and uncertainties that could cause QuadraMed's actual results to differ from forward-looking statements in its periodic reports filed with the Securities and Exchange Commission ("SEC"). QuadraMed's SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC's EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833).
Information from the "Top 20 Year-End Best in KLAS Awards" is ©2005 KLAS Enterprises, LLC. All Rights Reserved. QuadraMed, Affinity, and WinPFS are registered trademarks of QuadraMed Corporation. All other trademarks are the property of their respective holders.
Contact:
QuadraMed Corporation
Kevin Cleary, 703-989-7020
press@quadramed.com
or
Investor Relations, 703-742-5393
InvestorRelations@quadramed.com
Source: QuadraMed Corporation
Home | Why MATCH? | Open Positions | Submit Your Resume | Contact Us | Industry News | Links | 
